Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Rossi

Showing results (21-30 of 818) with videos related to

Pageof 82
Sort By:
Cardiovascular Drug Reviews|February 22, 2003
Dual ACE and NEP inhibitors: a review of the pharmacological properties of MDL 100240Gian Paolo Rossi
Hypertension (Dallas, Tex. : 1979)|August 19, 2009
Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?Gian Paolo Rossi
Handbook of Clinical Neurology|September 7, 2010
The clinical neurophysiology of tension-type headacheGiorgio Sandrini, Paolo Rossi
Functional Neurology|December 5, 2014
Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014Paolo Rossi, Giuseppe Nappi
Journal of Hypertension|August 5, 2016
ReplyGian Paolo Rossi, Valeria Bisogni
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2004
T-786C and G894T variants of the endothelial nitric oxide synthase gene and training-induced correction of endothelial dysfunction in coronary artery disease patientGian Paolo Rossi, Giuseppe Maiolino
Circulation|October 15, 2003
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failureGiuseppe Maiolino, Gian Paolo Rossi
Journal of Hypertension|February 13, 2016
A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)-AppGian Paolo Rossi, Valeria Bisogni,
Hypertension (Dallas, Tex. : 1979)|August 10, 2022
Aldosterone and Cardiovascular Damage: a New Lesson From an Old StudyGian Paolo Rossi, Giacomo Rossitto
European Heart Journal|September 11, 2008
Adiponectin and prognostic outcome in patients with coronary artery diseaseMaurizio Cesari, Gian Paolo Rossi
Pageof 82

Showing results (21-30 of 818) with videos related to

Sort By:
Pageof 82
Cardiovascular Drug Reviews|February 22, 2003
Dual ACE and NEP inhibitors: a review of the pharmacological properties of MDL 100240Gian Paolo Rossi
Hypertension (Dallas, Tex. : 1979)|August 19, 2009
Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?Gian Paolo Rossi
Handbook of Clinical Neurology|September 7, 2010
The clinical neurophysiology of tension-type headacheGiorgio Sandrini, Paolo Rossi
Functional Neurology|December 5, 2014
Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014Paolo Rossi, Giuseppe Nappi
Journal of Hypertension|August 5, 2016
ReplyGian Paolo Rossi, Valeria Bisogni
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2004
T-786C and G894T variants of the endothelial nitric oxide synthase gene and training-induced correction of endothelial dysfunction in coronary artery disease patientGian Paolo Rossi, Giuseppe Maiolino
Circulation|October 15, 2003
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failureGiuseppe Maiolino, Gian Paolo Rossi
Journal of Hypertension|February 13, 2016
A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)-AppGian Paolo Rossi, Valeria Bisogni,
Hypertension (Dallas, Tex. : 1979)|August 10, 2022
Aldosterone and Cardiovascular Damage: a New Lesson From an Old StudyGian Paolo Rossi, Giacomo Rossitto
European Heart Journal|September 11, 2008
Adiponectin and prognostic outcome in patients with coronary artery diseaseMaurizio Cesari, Gian Paolo Rossi
Pageof 82